Merit Medical Systems, Inc. $MMSI Shares Newly Purchased by First Eagle Investment Management LLC

First Eagle Investment Management LLC purchased a new stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 150,200 shares of the medical instruments supplier’s stock, valued at approximately $12,952,000.

Several other institutional investors have also recently made changes to their positions in the business. William Blair Investment Management LLC purchased a new position in shares of Merit Medical Systems in the second quarter worth approximately $78,894,000. Irenic Capital Management LP bought a new stake in Merit Medical Systems during the second quarter valued at approximately $37,623,000. The Manufacturers Life Insurance Company bought a new stake in Merit Medical Systems during the second quarter valued at approximately $33,591,000. Bank of New York Mellon Corp purchased a new stake in Merit Medical Systems during the second quarter valued at approximately $28,470,000. Finally, J. Goldman & Co LP purchased a new stake in Merit Medical Systems during the second quarter valued at approximately $16,835,000. Institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Stock Up 1.7%

NASDAQ MMSI opened at $85.93 on Thursday. Merit Medical Systems, Inc. has a 52 week low of $59.74 and a 52 week high of $94.85. The company has a quick ratio of 3.05, a current ratio of 4.52 and a debt-to-equity ratio of 0.42. The company has a market capitalization of $5.15 billion, a P/E ratio of 21.72, a price-to-earnings-growth ratio of 2.06 and a beta of 0.56. The stock’s 50-day moving average price is $87.87 and its 200-day moving average price is $77.48.

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last announced its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.04 by $0.08. The company had revenue of $416.24 million during the quarter, compared to the consensus estimate of $410.56 million. Merit Medical Systems had a return on equity of 14.12% and a net margin of 9.94%. The firm’s revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.92 EPS. On average, equities research analysts predict that Merit Medical Systems, Inc. will post 3.86 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have weighed in on MMSI. Wells Fargo & Company increased their price target on shares of Merit Medical Systems from $83.00 to $92.00 and gave the stock an “equal weight” rating in a research report on Friday, October 30th. Freedom Capital began coverage on shares of Merit Medical Systems in a research note on Tuesday, October 27th. They set a “hold” rating on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Merit Medical Systems from $95.00 to $110.00 and gave the company an “overweight” rating in a research report on Friday, October 30th. Robert W. Baird set a $98.00 price objective on Merit Medical Systems in a research note on Friday, July 31st. Finally, Bank of America upped their price objective on Merit Medical Systems from $92.00 to $97.00 and gave the stock a “neutral” rating in a research note on Thursday, August 13th. Eight equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $105.91.

Get Our Latest Stock Report on MMSI

Insider Buying and Selling

In other Merit Medical Systems news, insider Brian Lloyd sold 16,722 shares of the firm’s stock in a transaction that occurred on Monday, November 16th. The shares were sold at an average price of $86.33, for a total transaction of $1,443,610.26. Following the sale, the insider owned 60,132 shares in the company, valued at approximately $5,191,195.56. This trade represents a 21.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.70% of the company’s stock.

Merit Medical Systems Company Profile

(Free Report)

Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.

See Also

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI – Free Report).

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.